Global Transgenes Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-06-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-06-2024
- Company Age 25 Year, 12 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.65 Cr
as on 16-06-2024
- Revenue %
(FY 2023)
- Profit 12.58%
(FY 2023)
- Ebitda 1.03%
(FY 2023)
- Net Worth -0.17%
(FY 2023)
- Total Assets -1.67%
(FY 2023)
About Global Transgenes
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹2.65 Cr.
Jeevanlata Kagliwal, Sweta Kagliwal, Satish Raina, and One other member serve as directors at the Company.
- CIN/LLPIN
U73100MH2000PLC123602
- Company No.
123602
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 Jan 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Global Transgenes?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jeevanlata Kagliwal  | Director | 25-Mar-2019 | Current |
| Sweta Kagliwal | Director | 25-Mar-2019 | Current |
| Satish Raina | Director | 31-Dec-2006 | Current |
| Shrirang Agrawal | Director | 31-Dec-2006 | Current |
Financial Performance of Global Transgenes.
Global Transgenes Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 12.58% increase in profit. The company's net worth dipped by a decrease of 0.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Global Transgenes?
In 2023, Global Transgenes had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Agri-Tech (India) LimitedActive 31 years 5 monthsJeevanlata Kagliwal and Sweta Kagliwal are mutual person
Tapovan Paper And Board Mills LimitedActive 37 years 7 monthsSweta Kagliwal and Shrirang Agrawal are mutual person
Nath Bio-Technologies LimitedActive 33 years 4 monthsJeevanlata Kagliwal and Sweta Kagliwal are mutual person
Charges (Loans)
₹2.65 Cr
₹0
Charges Breakdown by Lending Institutions
- Department Of Biotechnology : 2.65 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jun 2011 | Department Of Biotechnology | ₹2.65 Cr | Open |
How Many Employees Work at Global Transgenes?
Global Transgenes has a workforce of 9 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Global Transgenes, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Global Transgenes's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
